{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:27:20Z","timestamp":1772141240916,"version":"3.50.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1093\/rheumatology\/kep332","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T07:11:28Z","timestamp":1258528288000},"page":"105-111","source":"Crossref","is-referenced-by-count":60,"title":["Prescription and comorbidity screening following consultation for acute gout in primary care"],"prefix":"10.1093","volume":"49","author":[{"given":"Edward","family":"Roddy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian D.","family":"Mallen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha L.","family":"Hider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin P.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,11,17]]},"reference":[{"key":"key\n\t\t\t\t20170225055616_B1","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","article-title":"British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the management of gout","volume":"46","author":"Jordan","year":"2007","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225055616_B2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225055616_B3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust NZ J Med"},{"key":"key\n\t\t\t\t20170225055616_B4","volume-title":"British National Formulary","author":"British Medical Association, Royal Pharmaceutical Society of Great Britain","year":"2008"},{"key":"key\n\t\t\t\t20170225055616_B5","first-page":"U2808","article-title":"Colchicine prescribing and safety monitoring in patients with gout","volume":"120","author":"Ly","year":"2007","journal-title":"NZ Med J"},{"key":"key\n\t\t\t\t20170225055616_B6","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bmj.327.7426.1275","article-title":"Colchicine in acute gout","volume":"327","author":"Morris","year":"2003","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20170225055616_B7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0895-4356(88)90127-8","article-title":"Gout and coronary heart disease: the Framingham Study","volume":"41","author":"Abbott","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20170225055616_B8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.2007.076232","article-title":"Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000\u20132005","volume":"67","author":"Annemans","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225055616_B9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archinte.165.7.742","article-title":"Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study","volume":"165","author":"Choi","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170225055616_B10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225055616_B11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.107.703389","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170225055616_B12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/rheumatology\/ken305","article-title":"Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile","volume":"47","author":"Choi","year":"2008","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225055616_B13","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/archinte.1997.00440340060005","article-title":"Gout and risk for subsequent coronary artery disease: the Meharry\u2013Hopkins study","volume":"157","author":"Gelber","year":"1997","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170225055616_B14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/fampra\/cmg413","article-title":"Gout, just a nasty event or a cardiovascular signal? A study from primary care","volume":"20","author":"Janssens","year":"2003","journal-title":"Fam Pract"},{"key":"key\n\t\t\t\t20170225055616_B15","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225055616_B16","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archinte.168.10.1104","article-title":"Long-term cardiovascular mortality among middle-aged men with gout","volume":"168","author":"Krishnan","year":"2008","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170225055616_B17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","article-title":"Gout epidemiology: results from the UK General Practice Research Database, 1990\u20131999","volume":"64","author":"Mikuls","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225055616_B18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225055616_B19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/keh679","article-title":"Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)","volume":"44","author":"Mikuls","year":"2005","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20170225055616_B20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s100670050005","article-title":"How is gout managed in primary care? A review of current practice and proposed guidelines","volume":"19","author":"Pal","year":"2000","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t20170225055616_B21","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/ard.2007.070755","article-title":"Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations","volume":"66","author":"Roddy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225055616_B22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","article-title":"Quality of care for gout in the US needs improvement","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225055616_B23","first-page":"1841","article-title":"A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arthritis in the province of Ontario","volume":"15","author":"Bellamy","year":"1988","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225055616_B24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5694\/j.1326-5377.1989.tb128510.x","article-title":"A survey of current prescribing practices of anti-inflammatory and urate-lowering drugs in gouty arthritis in New South Wales and Queensland","volume":"151","author":"Bellamy","year":"1989","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t20170225055616_B25","first-page":"147","article-title":"A survey of the management of gout in primary care","volume":"101","author":"Owens","year":"2008","journal-title":"Ir Med J"},{"key":"key\n\t\t\t\t20170225055616_B26","first-page":"1566","article-title":"Treatment of acute gout in hospitalized patients","volume":"34","author":"Petersel","year":"2007","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225055616_B27","first-page":"7","article-title":"Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases","volume":"57","author":"Jordan","year":"2007","journal-title":"Br J Gen Pract"},{"key":"key\n\t\t\t\t20170225055616_B28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1197\/jamia.M1362","article-title":"Data quality of general practice electronic health records: the impact of a program of assessments, feedback, and training","volume":"11","author":"Porcheret","year":"2004","journal-title":"J Am Med Inform Assoc"},{"key":"key\n\t\t\t\t20170225055616_B29","volume-title":"The Clinical Terms Version 3 (The Read codes)","author":"NHS Information Authority","year":"2000"},{"key":"key\n\t\t\t\t20170225055616_B30","first-page":"1232","article-title":"The misdiagnosis of gout and hyperuricemia","volume":"18","author":"Wolfe","year":"1991","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225055616_B31","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1053\/j.gastro.2005.08.003","article-title":"National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs","volume":"129","author":"Abraham","year":"2005","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170225055616_B32","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10067-008-0952-7","article-title":"Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly","volume":"27","author":"Juby","year":"2008","journal-title":"Clin Rheumatol"},{"key":"key\n\t\t\t\t20170225055616_B33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/ageing\/afm049","article-title":"Prevention of NSAID gastropathy in elderly patients. An observational study in general practice and nursing homes","volume":"36","author":"van Leen","year":"2007","journal-title":"Age Ageing"},{"key":"key\n\t\t\t\t20170225055616_B34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1053\/j.gastro.2006.12.007","article-title":"Risk of upper gastrointestinal complications among users of traditional NSAIDs and coxibs in the general population","volume":"132","author":"Garcia Rodriguez","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170225055616_B35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/00365520701192326","article-title":"Risk of upper gastrointestinal events with the use of various NSAIDs: a case-control study in a general population","volume":"42","author":"Helin-Salmivaara","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"key\n\t\t\t\t20170225055616_B36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/ard.54.2.86","article-title":"Missed opportunity following diagnosis of gout","volume":"54","author":"O\u2019Reilly","year":"1995","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/49\/1\/105\/10653244\/kep332.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T19:00:38Z","timestamp":1590260438000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/1789776\/Prescription"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,11,17]]},"published-print":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kep332","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,17]]}}}